Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/21920
Title: | Genetic Landscape of Epilepsy of Infancy with Migrating Focal Seizures. | Austin Authors: | Burgess, Rosemary;Wang, Shuyu;McTague, Amy;Boysen, Katja E;Yang, Xiaoling;Zeng, Qi;Myers, Kenneth A;Rochtus, Anne;Trivisano, Marina;Gill, Deepak;Sadleir, Lynette G;Specchio, Nicola;Guerrini, Renzo;Marini, Carla;Zhang, Yue-Hua;Mefford, Heather C;Kurian, Manju A;Poduri, Annapurna H;Scheffer, Ingrid E | Affiliation: | T. Y. Nelson Department of Neurology and Neurosurgery, Children's Hospital at Westmead, Sydney, New South Wales, Australia Division of Neurology, Department of Pediatrics, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada Epilepsy Genetics Program, Boston Children's Hospital, Boston, MA Department of Pediatrics, Peking University First Hospital, Beijing, China Department of Neurology, Harvard Medical School, Boston, MA.. Molecular Neurosciences, Developmental Neurosciences, University College London Great Ormond Street Institute of Child Health, London, United Kingdom Department of Neurology, Great Ormond Street Hospital for Children National Health Service Foundation Trust, London, United Kingdom.. Epilepsy Research Centre, Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia Research Institute of the McGill University Health Centre; Montreal, Quebec, Canada School of Clinical Sciences, Monash University, Monash Health, Melbourne, Victoria, Australia Florey Institute for Neuroscience and Mental Health, Melbourne, Victoria, Australia Department of Neurology, Royal Children's Hospital, Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia Murdoch Children's Research Institute, Melbourne, Victoria, Australia Molecular Neurosciences, Developmental Neurosciences, University College London Great Ormond Street Institute of Child Health, London, United Kingdom Epilepsy Genetics Program, Boston Children's Hospital, Boston, MA.. Rare and Complex Epilepsies Unit, Department of Neuroscience, Bambino Gesù Children's Hospital, Scientific Institute for Research and Health Care, Rome, Italy Department of Paediatrics and Child Health, University of Otago Wellington, Wellington, New Zealand Rare and Complex Epilepsies Unit, Department of Neuroscience, Bambino Gesù Children's Hospital, Scientific Institute for Research and Health Care, Rome, Italy Pediatric Neurology, Neurogenetics, and Neurobiology Unit and Laboratories, Children's Hospital A. Meyer-University of Florence, Florence, Italy Department of Pediatrics, Peking University First Hospital, Beijing, China Department of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, WA |
Issue Date: | 2019 | Date: | 2019-10-16 | Publication information: | Annals of neurology 2019; 86(6): 821-831 | Abstract: | Epilepsy of infancy with migrating focal seizures (EIMFS) is one of the most severe developmental and epileptic encephalopathies. We delineate the genetic causes and genotype-phenotype correlations of a large EIMFS cohort. Phenotypic and molecular data were analyzed on patients recruited through an international collaborative study. We ascertained 135 patients from 128 unrelated families. Ninety-three of 135 (69%) had causative variants (42/55 previously reported) across 23 genes, including 9 novel EIMFS genes: de novo dominant GABRA1, GABRB1, ATP1A3; X-linked CDKL5, PIGA; and recessive ITPA, AIMP1, KARS, WWOX. The most frequently implicated genes were KCNT1 (36/135, 27%) and SCN2A (10/135, 7%). Mosaicism occurred in 2 probands (SCN2A, GABRB3) and 3 unaffected mothers (KCNT1). Median age at seizure onset was 4 weeks, with earlier onset in the SCN2A, KCNQ2, and BRAT1 groups. Epileptic spasms occurred in 22% patients. A total of 127 patients had severe to profound developmental impairment. All but 7 patients had ongoing seizures. Additional features included microcephaly, movement disorders, spasticity, and scoliosis. Mortality occurred in 33% at median age 2 years 7 months. We identified a genetic cause in 69% of patients with EIMFS. We highlight the genetic heterogeneity of EIMFS with 9 newly implicated genes, bringing the total number to 33. Mosaicism was observed in probands and parents, carrying critical implications for recurrence risk. EIMFS pathophysiology involves diverse molecular processes from gene and protein regulation to ion channel function and solute trafficking. This article is protected by copyright. All rights reserved. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/21920 | DOI: | 10.1002/ana.25619 | ORCID: | 0000-0002-2664-4395 0000-0002-2311-2174 0000-0001-7831-4593 |
Journal: | Annals of neurology | PubMed URL: | 31618474 | Type: | Journal Article |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.